|
TBC1D20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.123900E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.899800E-03 |
| Normal-vs-Stage2 |
8.115200E-01 |
| Normal-vs-Stage3 |
2.781900E-04 |
| Normal-vs-Stage4 |
2.16119999999487E-05 |
| Stage1-vs-Stage2 |
5.802800E-03 |
| Stage1-vs-Stage3 |
1.033810E-01 |
| Stage1-vs-Stage4 |
1.912480E-02 |
| Stage2-vs-Stage3 |
5.447900E-04 |
| Stage2-vs-Stage4 |
2.211700E-04 |
| Stage3-vs-Stage4 |
4.667600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.209100E-04 |
| Normal-vs-AfricanAmerican |
5.370300E-02 |
| Normal-vs-Asian |
9.299200E-03 |
| Caucasian-vs-AfricanAmerican |
7.259200E-01 |
| Caucasian-vs-Asian |
4.474400E-01 |
| AfricanAmerican-vs-Asian |
9.550600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.220500E-03 |
| Normal-vs-Female |
4.541300E-03 |
| Male-vs-Female |
8.407000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.762800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.818800E-03 |
| Normal-vs-Age(61-80Yrs) |
5.959400E-03 |
| Normal-vs-Age(81-100Yrs) |
2.233600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.054200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.920800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.445800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.089800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.923600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.508000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.51840000000214E-05 |
| Classical-VS-Follicular |
1.012120E-02 |
| Classical-VS-Other |
1.146450E-01 |
| Classical-VS-Normal |
4.098600E-03 |
| Tall-VS-Follicular |
1.02500000043193E-07 |
| Tall-VS-Other |
8.400600E-01 |
| Tall-VS-Normal |
1.07089999978882E-07 |
| Follicular-VS-Other |
3.596500E-02 |
| Follicular-VS-Normal |
7.162400E-01 |
| Other-VS-Normal |
5.115900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.654300E-02 |
| Normal-vs-N1 |
1.58959999996267E-06 |
| N0-vs-N1 |
1.196820E-03 |
|
|
